Selected News & Events
Stealth BioTherapeutics Completes Mid-Cycle Review Meeting on Elamipretide for the Treatment of Barth Syndrome
Stealth BioTherapeutics Announces First Patient Enrolled in Global Phase 3 Clinical Program for Elamipretide in Patients with Dry Age-Related Macular Degeneration
Stealth BioTherapeutics’ Barth Syndrome NDA Receives Priority Review Designation
Stealth BioTherapeutics to Present at JMP Citizens Life Sciences Conference
Events Calendar
No events listed at this time.
@StealthBT on Twitter
Twitter feed is not available at the moment.
Contact Us
Stealth BioTherapeutics
275 Grove Street, Suite 3-107
Newton, MA 02466
(617) 600-6888
info@stealthbt.com